The AMA is in its third year of running publicly available workgroups that plan consensus code revisions for genomic tests, such as hereditary disease panels. The AMA workgroups hold meetings and discussions, and periodically, these are open to the public to listen in, and then join a Q&A session.
See an AMA webpage which is updated on a rolling basis:
Currently, Workgroup A is looking at recessive hereditary disease testing (both core panels, like CFTR and SMN, and large panels).* Workgroup B is looking at cancer hereditary panels, mostly dominant genes (both limited Lynch panels, like 81435, and large multi-cancer panels).
I've clipped the current registration opportunities below.